Transketolase (TKT) Peptide
-
- Target See all TKT products
- TKT (Transketolase (TKT))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequence
- ESYHKPDQQK LQALKDTANR LRISSIQATT AAGSGHPTSC CSAAEIMAVL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of TKT antibody,
Alternative Names: TKT control peptide, TKT antibody Blocking Peptide, Anti-TKT Blocking Peptide, Transketolase Blocking Peptide, Wernicke-Korsakoff Syndrome Blocking Peptide, FLJ34765 Blocking Peptide, TKT1 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- TKT (Transketolase (TKT))
- Background
- TKT belongs to the transketolase family. TKT has been implicated in the latent genetic disease Wernicke-Korsakoff syndrome (WKS), which causes specific brain damage.
- Molecular Weight
- 68 kDa
-